AXGN
Price
$17.16
Change
-$0.22 (-1.27%)
Updated
Sep 25, 03:16 PM (EDT)
Capitalization
800.16M
47 days until earnings call
XRAY
Price
$12.31
Change
-$0.56 (-4.35%)
Updated
Sep 25, 04:18 PM (EDT)
Capitalization
2.57B
35 days until earnings call
Interact to see
Advertisement

AXGN vs XRAY

Header iconAXGN vs XRAY Comparison
Open Charts AXGN vs XRAYBanner chart's image
Axogen
Price$17.16
Change-$0.22 (-1.27%)
Volume$550
Capitalization800.16M
DENTSPLY SIRONA
Price$12.31
Change-$0.56 (-4.35%)
Volume$3.47K
Capitalization2.57B
AXGN vs XRAY Comparison Chart in %
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. XRAY commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Hold and XRAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (AXGN: $17.39 vs. XRAY: $12.87)
Brand notoriety: AXGN and XRAY are both not notable
AXGN represents the Medical/Nursing Services, while XRAY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AXGN: 54% vs. XRAY: 77%
Market capitalization -- AXGN: $800.16M vs. XRAY: $2.57B
AXGN [@Medical/Nursing Services] is valued at $800.16M. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.57B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $233.03B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $159.16B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, AXGN is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • AXGN’s TA Score: 4 bullish, 3 bearish.
  • XRAY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both AXGN and XRAY are a good buy in the short-term.

Price Growth

AXGN (@Medical/Nursing Services) experienced а +3.39% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -4.17% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.13%. For the same industry, the average monthly price growth was +3.01%, and the average quarterly price growth was +9.53%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.33%. For the same industry, the average monthly price growth was -3.57%, and the average quarterly price growth was +7.41%.

Reported Earning Dates

AXGN is expected to report earnings on Nov 11, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.13% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-3.33% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.57B) has a higher market cap than AXGN($800M). AXGN YTD gains are higher at: 5.522 vs. XRAY (-30.799). AXGN has higher annual earnings (EBITDA): 10.8M vs. XRAY (-689M). XRAY has more cash in the bank: 359M vs. AXGN (29.9M). AXGN has less debt than XRAY: AXGN (68.2M) vs XRAY (2.49B). XRAY has higher revenues than AXGN: XRAY (3.67B) vs AXGN (203M).
AXGNXRAYAXGN / XRAY
Capitalization800M2.57B31%
EBITDA10.8M-689M-2%
Gain YTD5.522-30.799-18%
P/E RatioN/AN/A-
Revenue203M3.67B6%
Total Cash29.9M359M8%
Total Debt68.2M2.49B3%
FUNDAMENTALS RATINGS
AXGN vs XRAY: Fundamental Ratings
AXGN
XRAY
OUTLOOK RATING
1..100
6452
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
4265
P/E GROWTH RATING
1..100
10084
SEASONALITY SCORE
1..100
7527

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is somewhat better than the same rating for AXGN (42). This means that XRAY’s stock grew somewhat faster than AXGN’s over the last 12 months.

AXGN's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as XRAY (100). This means that AXGN’s stock grew similarly to XRAY’s over the last 12 months.

AXGN's SMR Rating (93) in the Medical Specialties industry is in the same range as XRAY (97). This means that AXGN’s stock grew similarly to XRAY’s over the last 12 months.

AXGN's Price Growth Rating (42) in the Medical Specialties industry is in the same range as XRAY (65). This means that AXGN’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's P/E Growth Rating (84) in the Medical Specialties industry is in the same range as AXGN (100). This means that XRAY’s stock grew similarly to AXGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNXRAY
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 10 days ago
58%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHPAX18.28N/A
N/A
Diamond Hill Mid Cap Inv
JVMCX28.01-0.11
-0.39%
JHancock Disciplined Value Mid Cap C
HBGIX22.19-0.10
-0.45%
Hartford Disciplined Equity HLS IB
PTMCX19.54-0.09
-0.46%
PGIM Quant Solutions Large-Cap Cor Eq C
MPGVX16.50-0.08
-0.48%
Mondrian Global Equity Value

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with VMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then VMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
+0.52%
VMD - AXGN
36%
Loosely correlated
+0.44%
XRAY - AXGN
33%
Poorly correlated
-0.69%
GMED - AXGN
32%
Poorly correlated
-2.56%
CLPT - AXGN
32%
Poorly correlated
+58.55%
IART - AXGN
31%
Poorly correlated
-0.43%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-0.69%
NVST - XRAY
55%
Loosely correlated
-1.39%
QDEL - XRAY
49%
Loosely correlated
-2.73%
KIDS - XRAY
47%
Loosely correlated
-0.26%
STE - XRAY
46%
Loosely correlated
-1.30%
AZTA - XRAY
46%
Loosely correlated
-1.32%
More